Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Words of Wisdom. Re: Genomic Classifier Identifies Men with Adverse Pathology After Radical Prostatectomy Who Benefit from Adjuvant Radiation Therapy.

Chan J, Roach M.

Eur Urol. 2016 Mar;69(3):539-40. doi: 10.1016/j.eururo.2015.12.026. No abstract available.

PMID:
26867726
2.

Re: Genomic Classifier Identifies Men with Adverse Pathology After Radical Prostatectomy Who Benefit from Adjuvant Radiation Therapy.

Isbarn H, Giannarini G.

Eur Urol. 2015 Aug;68(2):337-8. doi: 10.1016/j.eururo.2015.03.014. No abstract available.

PMID:
26149727
3.

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.

Den RB, Yousefi K, Trabulsi EJ, Abdollah F, Choeurng V, Feng FY, Dicker AP, Lallas CD, Gomella LG, Davicioni E, Karnes RJ.

J Clin Oncol. 2015 Mar 10;33(8):944-51. doi: 10.1200/JCO.2014.59.0026. Epub 2015 Feb 9. Erratum in: J Clin Oncol. 2015 Apr 20;33(12):1416.

4.

Outcomes for radiation therapy after radical prostatectomy for prostate cancer: what really matters?

Montie JE, Hussain M.

BJU Int. 2007 Sep;100(3):485-6. Epub 2007 Jul 3. No abstract available.

5.
6.

Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?

Simon RM, Howard LE, Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Vidal AC.

BJU Int. 2016 Jun;117(6):897-903. doi: 10.1111/bju.13182. Epub 2015 Jun 23.

7.

Post-prostatectomy radiation therapy for locally recurrent prostate cancer.

Isharwal S, Stephenson AJ.

Expert Rev Anticancer Ther. 2017 Nov;17(11):1003-1012. doi: 10.1080/14737140.2017.1378575. Epub 2017 Sep 18. Review.

PMID:
28922958
8.

Is postoperative irradiation after radical prostatectomy necessary?

Van Poppel H, Vanuytsel L, Petrovich Z, Baert L, Boccon-Gibod L, Bolla M, Artignan X, Balosso J, Chirpaz E.

Eur J Cancer. 1999 Dec;35(13):1763-70. Review. No abstract available.

PMID:
10673989
9.

Radical prostatectomy in high-grade prostate cancer, salvage and adjuvant radiotherapy.

Brodak M, Kosina J, Holub L, Louda M, Odrazka K, Dolezel M, Sefrová J, Jansa J, Pacovsky J.

Urol Int. 2011;86(2):146-51. doi: 10.1159/000320494. Epub 2010 Oct 22.

PMID:
20975252
10.

Adjuvant versus salvage radiotherapy following radical prostatectomy: do the AUA/ASTRO guidelines have all the answers?

Su MZ, Kneebone AB, Woo HH.

Expert Rev Anticancer Ther. 2014 Nov;14(11):1265-70. doi: 10.1586/14737140.2014.972381. Review.

PMID:
25367321
11.
12.

The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer.

Gandaglia G, Cozzarini C, Mottrie A, Bossi A, Fossati N, Montorsi F, Briganti A.

Curr Oncol Rep. 2015 Dec;17(12):53. doi: 10.1007/s11912-015-0478-5. Review.

PMID:
26449841
13.

Post-radical prostatectomy management options for the positive surgical margin: argument for adjuvant radiotherapy.

Chin JL.

Urol Oncol. 2009 Jan-Feb;27(1):87-8. doi: 10.1016/j.urolonc.2008.04.005. Review.

PMID:
19111805
14.

Adjuvant radiation therapy after radical prostatectomy: when is it indicated?

Graham SM, Holzbeierlein JM.

Curr Urol Rep. 2009 May;10(3):194-8. Review.

PMID:
19371476
15.

The need for a personalized approach for prostate cancer management.

Sedelaar JP, Schalken JA.

BMC Med. 2015 May 9;13:109. doi: 10.1186/s12916-015-0344-1.

16.

Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.

Eisenberg MS, Karnes RJ, Kaushik D, Rangel L, Bergstralh EJ, Boorjian SA.

J Urol. 2013 Nov;190(5):1735-41. doi: 10.1016/j.juro.2013.05.053. Epub 2013 May 29.

PMID:
23727312
17.

Quality of Radiation Therapy Referral and Utilisation Post-prostatectomy: A Population-based Study of Time Trends.

Jin CJ, Brundage MD, Cook EF, Miao Q, Hanna TP.

Clin Oncol (R Coll Radiol). 2016 Dec;28(12):783-789. doi: 10.1016/j.clon.2016.07.006. Epub 2016 Jul 25.

PMID:
27461732
18.
19.

A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.

Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E.

Eur Urol. 2015 Apr;67(4):778-86. doi: 10.1016/j.eururo.2014.10.036. Epub 2014 Nov 12.

PMID:
25466945
20.

High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.

Savdie R, Horvath LG, Benito RP, Rasiah KK, Haynes AM, Chatfield M, Stricker PD, Turner JJ, Delprado W, Henshall SM, Sutherland RL, Kench JG.

BJU Int. 2012 Jun;109(12):1794-800. doi: 10.1111/j.1464-410X.2011.10572.x. Epub 2011 Oct 12.

Supplemental Content

Support Center